Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
EJNMMI Research
Published in: EJNMMI Research 1/2013

Open Access 01-12-2013 | Original research

Characterization of fast-decaying PET radiotracers solely through LC-MS/MS of constituent radioactive and carrier isotopologues

Authors: H Umesha Shetty, Cheryl L Morse, Yi Zhang, Victor W Pike

Published in: EJNMMI Research | Issue 1/2013

Login to get access

Abstract

Background

The characterization of fast-decaying radiotracers that are labeled with carbon-11 (t 1/2 = 20.38 min), including critical measurement of specific radioactivity (activity per mole at a specific time) before release for use in positron-emission tomography (PET), has relied heavily on chromatographic plus radiometric measurements, each of which may be vulnerable to significant errors. Thus, we aimed to develop a mass-specific detection method using sensitive liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) for identifying 11C-labeled tracers and for verifying their specific radioactivities.

Methods

The LC-MS/MS was tuned and set up with methods to generate and measure the product ions specific for carbon-11 species and M + 1 carrier (predominantly the carbon-13 isotopologue) in four 11C-labeled tracers. These radiotracers were synthesized and then analyzed before extensive carbon-11 decay. The peak areas of carbon-11 species and M + 1 carrier from the LC-MS/MS measurement and the calculated abundances of carbon-12 carrier and M + 1 radioactive species gave the mole fraction of carbon-11 species in each sample. This value upon multiplication with the theoretical specific radioactivity of carbon-11 gave the specific radioactivity of the radiotracer.

Results

LC-MS/MS of each 11C-labeled tracer generated the product ion peaks for carbon-11 species and M + 1 carrier at the expected LC retention time. The intensity of the radioactive peak diminished as time elapsed and was undetectable after six half-lives of carbon-11. Measurements of radiotracer-specific radioactivity determined solely by LC-MS/MS at timed intervals gave a half-life for carbon-11 (20.43 min) in excellent agreement with the value obtained radiometrically. Additionally, the LC-MS/MS measurement gave specific radioactivity values (83 to 505 GBq/μmol) in good agreement with those from conventional radiometric methods.

Conclusions

11C-Labeled tracers were characterized at a fundamental level involving isolation and mass detection of extremely low-abundance carbon-11 species along with the M + 1 carrier counterpart. This LC-MS/MS method for characterizing fast-decaying radiotracers is valuable in both the development and production of PET radiopharmaceuticals.
Appendix
Available only for authorised users
Literature
1.
Fowler JS, Wolf AP: Working against time: rapid radiotracer synthesis and imaging the human brain. Acc Chem Res 1997, 30: 181–188. 10.1021/ar960068cCrossRef
2.
Miller PW, Long NJ, Vilar R, Gee AD: Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed 2008, 47: 8998–9033. 10.1002/anie.200800222CrossRef
3.
Cai L, Lu S, Pike VW: Chemistry with [18F]fluoride ion. Eur J Org Chem 2008, 2008: 2853–2873. 10.1002/ejoc.200800114CrossRef
4.
Meyer G-J: Some aspects of radioanalytical quality control of cyclotron-produced short-lived radiopharmaceuticals. Radiochim Acta 1982, 30: 175–184.
5.
Passchier J: Fast high performance liquid chromatography in PET quality control and metabolite analysis. Quart J Nucl Med Mol Imaging 2009, 53: 411–416.
6.
Kung M-P, Kung HF: Mass effect of injected dose in small rodent imaging by SPECT and PET. Nucl Med Biol 2005, 32: 673–678. 10.1016/j.nucmedbio.2005.04.002CrossRefPubMed
7.
Mizrahi R, Houle S, Vitcu I, Ng A, Wilson AA: Side effects profile in humans of [11C]-(+)-PHNO, a dopamine D2/3 agonist ligand for PET. J Nucl Med 2010, 51: 496–497. 10.2967/jnumed.109.072314CrossRefPubMed
8.
Madsen K, Marner L, Haahr M, Gillings N, Knudsen GM: Mass dose effects and in vivo affinity in brain PET receptor studies - a study of cerebral 5-HT4 receptor binding with [11C]SB207145. Nucl Med Biol 2011, 38: 1085–1091. 10.1016/j.nucmedbio.2011.04.006CrossRefPubMed
9.
Zimmerman BE, Cessna JT: Development of a traceable calibration methodology for solid 68Ge/68Ga sources used as a calibration surrogate for 18F in radionuclide activity calibrators. J Nucl Med 2010, 51: 448–453. 10.2967/jnumed.109.070300CrossRefPubMed
10.
Mo L, Reinhard MI, Davies JB, Alexiev D, Baldock C: Calibration of the Capintec CRC-712M dose calibrator for 18F. Appl Radiat Isot 2006, 64: 485–489. 10.1016/j.apradiso.2005.09.006CrossRefPubMed
11.
Zimmerman BE, Kubicek GJ, Cessna JT, Plascjak PS, Eckelman WC: Radioassays and experimental evaluation of dose calibrator settings for 18F. Appl Radiat Isot 2001, 54: 113–122. 10.1016/S0969-8043(99)00260-2CrossRefPubMed
12.
Zimmerman B, Kinahan P, Galbraith W, Allberg K, Mawlawi O: Multicenter comparison of dose calibrator accuracy for PET imaging using a standardized source [abstract]. J Nucl Med 2009,50(Suppl 2):472P.
13.
Tyler DK, Baker M, Woods MJ: NPL secondary standard radionuclide calibrator. Syringe calibration factors for radionuclides used in nuclear medicine. Appl Radiat Isot 2002, 56: 343–347. 10.1016/S0969-8043(01)00212-3CrossRefPubMed
14.
Cessna JT, Schultz MK, Leslie T, Bores N: Radionuclide calibrator measurements of 18F in a 3 ml plastic syringe. Appl Radiat Isot 2008, 66: 988–993. 10.1016/j.apradiso.2008.02.046CrossRefPubMed
15.
Woods DH, Baker MI, Keightley JD, Keightley LJ, Makepeace JL, Pearce AK, Woodman AP, Woods MJ, Woods SA, Waters S: Standardisation of 11C. Appl Radiat Isot 2002, 56: 327–330. 10.1016/S0969-8043(01)00209-3CrossRefPubMed
16.
Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW: Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J Med Chem 2008, 51: 17–30. 10.1021/jm0707370CrossRefPubMed
17.
Fujita M, Imaizumi M, Zoghbi SS, Fujimora Y, Farris AG, Suhara T, Hong J, Pike VW, Innis RB: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 2008, 40: 43–52. 10.1016/j.neuroimage.2007.11.011CrossRefPubMed
18.
Lazarova N, Zoghbi SS, Hong J, Seneca N, Tuan E, Gladding RL, Liow J-S, Taku A, Innis RB, Pike VW: Synthesis and evaluation of [ N-methyl-11C ] N -desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function. J Med Chem 2008, 51: 6034–6043. 10.1021/jm800510mCrossRefPubMed
19.
Kreisl WC, Liow J-S, Kimura N, Seneca N, Zoghbi SS, Morse CL, Herscovitch P, Pike VW, Innis RB: P-glycoprotein function at the blood–brain barrier in humans can be quantified with the substrate radiotracer 11C- N-desmethyl -loperamide. J Nucl Med 2010, 51: 559–566. 10.2967/jnumed.109.070151CrossRefPubMed
20.
Donohue SR, Krushinski JH, Pike VW, Chernet E, Phebus L, Chesterfield AK, Felder CC, Halldin C, Schaus JM: Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging. J Med Chem 2008, 51: 5833–5842. 10.1021/jm800416mCrossRefPubMed
21.
Terry GE, Liow J-S, Zoghbi SS, Hirvonen J, Farris AG, Lerner A, Tauscher JT, Schaus JM, Phebus L, Felder CC, Morse CL, Hong JS, Pike VW, Halldin C, Innis RB: Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage 2009, 48: 362–370. 10.1016/j.neuroimage.2009.06.059CrossRefPubMed
22.
DaSilva JN, Lourenco CM, Meyer JH, Hussey D, Potter WZ, Houle S: Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography. Eur J Nucl Med 2002, 29: 1680–1683. 10.1007/s00259-002-0950-yCrossRef
23.
Lide DR: CRC Handbook of Chemistry and Physics. 83rd edition. Boca Raton: CRC; 2002.
24.
Azuelos G, Kitching JE: Half-lives of some T = ½ mirror decays. Phys Rev C 1975, 12: 563–566. 10.1103/PhysRevC.12.563CrossRef
25.
Pike VW, Waters SL, Aigbirhio FI, Makepeace J, Tanner RJN: Novel use of an isotope separator to determine the position of fluorine-18 in labelled 1,1,1,2-tetrafluoroethanes. Org Mass Spectrom 1994, 29: 499–504. 10.1002/oms.1210290910CrossRef
26.
Shetty HU, Morse CL, Zhang Y, Pike VW: Characterization of PET radiotracers through LC-MS/MS measurement of the radiotracer and accompanying [13C]carrier [abstract]. In Proceedings of the 58th ASMS Conference on Mass Spectrometry and Allied Topics: May 23–27 2010; Salt Lake City. Santa Fe: ASMS; 2010. MP24:519
Metadata
Title
Characterization of fast-decaying PET radiotracers solely through LC-MS/MS of constituent radioactive and carrier isotopologues
Authors
H Umesha Shetty
Cheryl L Morse
Yi Zhang
Victor W Pike
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2013
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/2191-219X-3-3

Other articles of this Issue 1/2013

EJNMMI Research 1/2013 Go to the issue

Original research

Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans

Original research

Noninvasive k3 estimation method for slow dissociation PET ligands: application to [11C]Pittsburgh compound B

Original research

Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry

Original research

Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes

Original research

Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective

Original research

[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models